Home Parexel Biotech

Parexel Biotech

acquired
IPO Delisting
Biopharmaceutical Service Provider

Basic Information

Parexel International is an American biopharmaceutical service provider. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. As the world's second-largest clinical research organization, it has helped develop approximately 95% of the top 200 best-selling biopharmaceuticals currently on the market. This is achieved by offering a suite of biopharmaceutical services that assist global clients in transforming scientific discoveries into new treatment methods. From clinical trials to regulatory, consulting, and market access services, the company’s therapies and technologies are underpinned by a profound belief in the work they do.
Parexel Biotech, Inc.
Newton,Massachusetts,United States of America
more than 500 people
January 01, 1983
info@parexel.com